Filing Flows › Strata Critical Medical (SRTA) › Q1 2025
Strata Critical Medical (SRTA) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 12, 2025
Strata Critical Medical (SRTA) reported revenue of $54.3M for the first quarter 2025 (Q1 2025), +5% from a year earlier and -0.1% from the quarter before. Operating margin was -14.0%, net loss $3.5M (6.4% of revenue).
Strata Critical Medical, Q1 2025: revenue $54.3M (+5% year over year), operating margin -14.0%, net loss $3.5M, operating cash flow −$246K. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $54.3M | -0.1% | +5% |
| Operating profit | −$7.6M | — | — |
| Net earnings | −$3.5M | — | — |
| Operating cash flow | −$246K | — | — |
What changed
Revenue was $54.3M in Q1 2025, up 5% year over year and roughly flat from the previous quarter.
Gross margin was 13.0%. Operating costs exceeded revenue by $7.6M, an operating margin of -14.0%. The fastest-growing cost line was Other operating costs (+244%). The quarter ended with a net loss of $3.5M, narrower than the previous quarter's $9.8M loss. Non-operating items added $4.1M, -116% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$246K. Non-cash charges added back $1.7M of depreciation and amortization and $4.2M of share-based compensation. Working capital and other items used $2.7M. Capital expenditures of $2.6M exceeded it, leaving free cash flow of −$2.9M.
Questions
What was Strata Critical Medical's revenue in the first quarter 2025?
Strata Critical Medical (SRTA) reported revenue of $54.3M for the first quarter 2025 (Q1 2025), +5% from a year earlier and -0.1% from the quarter before.
Was Strata Critical Medical profitable in the first quarter 2025?
Operating loss was $7.6M (-14.0% of revenue) and net loss $3.5M.